免疫治疗在早期乳腺癌中的作用:过去,现在和未来
Karissa Britten1, Aditya Bardia2, Nicholas McAndrew1
1Division of Hematology-Oncology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Targeted oncology
|June 20, 2025
概括
免疫检查点抑制剂 (ICI) 正在改变癌症护理,目前正在进行的研究正在探索它们在早期乳腺癌中的应用. 虽然对一些亚型有希望,但需要进一步研究来优化结果并确定预测生物标志物.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- 自2011年以来,免疫检查点抑制剂 (ICI) 已显著推进癌症治疗,已被批准用于多种癌症类型.
- 现在ICI已经成为各种癌症的前线治疗方法,包括肺癌,结肠直肠癌,头癌,泌尿生殖和皮肤癌.
- 乳腺癌中ICI的应用,特别是早期的乳腺癌,仍然是一个活跃的研究领域.
研究的目的:
- 审查免疫检查点抑制剂 (ICI) 在癌症治疗中的历史发展和当前状态.
- 检查评估ICI在早期乳腺癌的关键临床试验.
- 讨论未来的研究方向和生物标志物在预测乳腺癌ICI反应中的作用.
主要方法:
- 对免疫检查点抑制剂 (ICI) 的关键临床试验和FDA批准的审查.
- 对ICI在早期乳腺癌亚型,包括三阴性,雌激素受体阳性和HER2阳性疾病中的疗效的当前数据的分析.
- 讨论正在进行的研究,重点关注患者选择的生物标志物发现.
主要成果:
- 布罗利祖马布是FDA批准的高风险,早期的三阴性乳腺癌,结合化疗,基于KEYNOTE-522.
- 在早期三阴性乳腺癌中ICI的疗效在试验中显示出不一致的生存结果.
- 对于早期雌激素受体阳性乳腺癌中的ICI存在有限但有希望的数据;对HER2-阳性的研究更受限制.
结论:
- 免疫检查点抑制剂 (ICI) 代表了瘤学的重大进步,在几种晚期癌症中发挥了既定的作用.
- 在早期乳腺癌中使用ICI正在发展,目前的批准仅限于特定高风险的三阴性病例.
- 进一步的研究,包括生物标志物识别,对于扩大免疫治疗在不同乳腺癌患者群体中的有效使用至关重要.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Cancer Vaccines
520
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
520
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


